Meyka AI API is live for developers.Start building.
Advertisement
TRxADE HEALTH, Inc.

TRxADE HEALTH, Inc. (MEDS) Stock Overview

Explore TRxADE HEALTH, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MEDS●NASDAQ
HealthcareMedical - Pharmaceuticals
$7.59
$0.33(4.55%)
U.S. Market opens in 52h 50m
Advertisement

TRxADE HEALTH, Inc. (MEDS)

Meyka AI Score

Z

Key Financials

Market Cap13.3M
P/E Ratio-0.07
EPS (TTM)$-24.38
ROE-1.21%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$2.73

MEDS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TRxADE HEALTH, Inc. (MEDS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.07 and a market capitalization of 13.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
7.20%
1-Month Change
N/A
3-Month Change
-48.51%
6-Month Change
18.04%
Year-to-Date (YTD) Change
41.87%
1-Year Change
8.74%
3-Year Change
-88.39%
5-Year Change
-92.33%
All-Time (Max) Change
-99.99%

Contact Information

https://www.trxadehealth.com
800 261 0281
3840 Land O’ Lakes Boulevard, Land O'Lakes, FL, 34639

Company Facts

80 Employees
IPO DateFeb 6, 2014
CountryUS

Frequently Asked Questions